Develops innovative immunotherapies
Genticel has raised €31M across 2 funding rounds from 4 investors, most recently a Series D+ round in Apr 2013. Based in Argueil, France; founded 2001; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
